CVS Health Corp (CVS) is slightly overvalued and Humana Inc (HUM) is fairly valued.
Both trade above our estimate of their intrinsic value. HUM is the closer of the two: -4%, against -10% for CVS.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $79.35; the price of $87.10 is 10% above that value, and 82% of that value comes from beyond year five.
Leak Score 36/100 on 9 of 12 signals
Discounting its cash flows at 8.3% (average of 3 methods) values the shares at $358.19; the price of $372.00 is 4% above that value, and 79% of that value comes from beyond year five.
Leak Score 36/100 on 10 of 12 signals
| Metric | CVS | HUM |
|---|---|---|
| Verdict | Slightly overvalued | Fairly valued |
| Price | $87.10 | $372.00 |
| Intrinsic value | $79.35 | $358.19 |
| Margin of safety | -10% | -4% |
| Leak Score | 36/100 (9/12) | 36/100 (10/12) |
| Market cap | $111.4B | $44.7B |
| Revenue growth, 5 years | 8.4% | 10.9% |
| Operating margin | 3.5% | 1.9% |
| Net margin | 1.2% | 0.9% |
| Return on equity | 6.2% | 6.8% |
| Debt to equity | 0.96 | 0.74 |
| P/E | 23.0x | 35.2x |
| Forward P/E | 10.2x | 22.1x |
| P/B | 1.4x | 2.3x |
| Dividend yield | 3.1% | 1.0% |